Sanimed Société Anonyme, an industrial company, manufactures and sells ceramic sanitary ware for kitchens and bathrooms.
Price History & Performance
|Historical stock prices|
|Current Share Price||د.ت2.20|
|52 Week High||د.ت1.59|
|52 Week Low||د.ت2.20|
|1 Month Change||0%|
|3 Month Change||n/a|
|1 Year Change||35.80%|
|3 Year Change||n/a|
|5 Year Change||n/a|
|Change since IPO||-51.97%|
Recent News & Updates
|SANIMED||TN Building||TN Market|
Return vs Industry: SANIMED exceeded the TN Building industry which returned 26.5% over the past year.
Return vs Market: SANIMED exceeded the TN Market which returned -1.2% over the past year.
Stable Share Price: Insufficient data to determine SANIMED's volatility over the past 3 months.
Volatility Over Time: Insufficient data to determine SANIMED's volatility change over the past year.
About the Company
Sanimed Société Anonyme, an industrial company, manufactures and sells ceramic sanitary ware for kitchens and bathrooms. It offers bathroom components, including washbasins, such as built-in washbasins, and column mounted or suspended washbasins; toilet bowls; bidets; shower trays; decorated bowls; kitchen sinks; and various other products. The company was founded in 1998 and is headquartered in Sfax, Tunisia.
Sanimed Société Anonyme Fundamentals Summary
|SANIMED fundamental statistics|
Is SANIMED overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|SANIMED income statement (TTM)|
|Cost of Revenue||د.ت29.30m|
Last Reported Earnings
Jun 30, 2021
Next Earnings Date
|Earnings per share (EPS)||-0.30|
|Net Profit Margin||-6.89%|
How did SANIMED perform over the long term?See historical performance and comparison
Is Sanimed Société Anonyme undervalued compared to its fair value and its price relative to the market?
Price to Book (PB) ratio
Share Price vs. Fair Value
Below Fair Value: Insufficient data to calculate SANIMED's fair value to establish if it is undervalued.
Significantly Below Fair Value: Insufficient data to calculate SANIMED's fair value to establish if it is undervalued.
Price To Earnings Ratio
PE vs Industry: SANIMED is unprofitable, so we can't compare its PE Ratio to the African Building industry average.
PE vs Market: SANIMED is unprofitable, so we can't compare its PE Ratio to the TN market.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate SANIMED's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: SANIMED is good value based on its PB Ratio (1.2x) compared to the XF Building industry average (1.6x).
How is Sanimed Société Anonyme forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Forecasted Capital Goods industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Sanimed Société Anonyme has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
How has Sanimed Société Anonyme performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: SANIMED is currently unprofitable.
Growing Profit Margin: SANIMED is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: SANIMED is unprofitable, and losses have increased over the past 5 years at a rate of 63.8% per year.
Accelerating Growth: Unable to compare SANIMED's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: SANIMED is unprofitable, making it difficult to compare its past year earnings growth to the Building industry (6.6%).
Return on Equity
High ROE: SANIMED has a negative Return on Equity (-15.49%), as it is currently unprofitable.
How is Sanimed Société Anonyme's financial position?
Financial Position Analysis
Short Term Liabilities: SANIMED's short term assets (TND64.3M) exceed its short term liabilities (TND62.9M).
Long Term Liabilities: SANIMED's short term assets (TND64.3M) do not cover its long term liabilities (TND69.4M).
Debt to Equity History and Analysis
Debt Level: SANIMED's debt to equity ratio (386.3%) is considered high.
Reducing Debt: SANIMED's debt to equity ratio has increased from 226.6% to 386.3% over the past 5 years.
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: SANIMED has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: SANIMED has less than a year of cash runway if free cash flow continues to reduce at historical rates of 4.1% each year
What is Sanimed Société Anonyme current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate SANIMED's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate SANIMED's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if SANIMED's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if SANIMED's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of SANIMED's dividend in 3 years as they are not forecast to pay a notable one for the TN market.
How experienced are the management team and are they aligned to shareholders interests?
Sanimed Société Anonyme has no CEO, or we have no data on them.
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Sanimed Société Anonyme's employee growth, exchange listings and data sources
- Name: Sanimed Société Anonyme
- Ticker: SANIMED
- Exchange: BVMT
- Founded: 1998
- Industry: Building Products
- Sector: Capital Goods
- Market Cap: د.ت27.280m
- Shares outstanding: 12.40m
- Website: https://www.sanimed.com.tn
Number of Employees
- Sanimed Société Anonyme
- Route de gremda km 10.5
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/10/25 15:01|
|End of Day Share Price||2021/09/07 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.